Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: DsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C

Hepatology

Volumn 32, Issue 5, 2000, Pages 1089-1095

  Yu, Shin Han ^a   Nagayama, Kazuyoshi ^a   Enomoto, Nobuyuki ^a   Izumi, Namiki ^b   Marumo, Fumiaki ^a   Sato, Chifumi ^a  

^a MUSASHINO RED CROSS HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOUBLE STRANDED RNA; INTERFERON; MESSENGER RNA; PROTEIN KINASE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; AUTOIMMUNE HEPATITIS; CHRONIC HEPATITIS; FEMALE; GENE OVEREXPRESSION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERFERON INDUCTION; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

EID: 0033761047     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2000.19287     Document Type: Article

References (34)

1. The interferon system. A bird's eye view of its biochemistry
2. 2',5'-Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis
3. Changes of serum 2',5'-oligoadenylate synthetase activity during interferon treatment of chronic hepatitis C
4. In vivo and In vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus
5. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-alpha therapy
6. The MxA protein levels in whole blood lysates of patients with various viral infections
7. Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma
8. Detection of interferon-alpha expression by PCR in patients With chronic hepatitis C and hepatitis non-A, non-B
9. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein
10. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: Molecular mechanisms of kinase regulation
11. Cloning and characterization of RNase L inhibitor. A new component of the interferon-regulated 2-5A pathway
12. Classification of chronic hepatitis: Diagnosis, grading and staging
13. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
14. Isolation of the interferon-inducible RNA-dependent protein kinase Pkr promotor and identification of a novel DNA element within the 5'-flanking region of human and mouse Pkr genes
15. Identification of genes differentially regulated by interferon α, β, γ using oligonucleotide arrays
16. The double-stranded RNA-dependent protein kinase PKR: Structure and function
17. The war against the interferon-induced dsRNA-activated protein kinase: Can viruses win?
18. Mechanism of interferon action: Autoregulation of RNA-dependent P1/elF-2 alpha protein kinase (PKR) expression in transfected mammalian cells
19. The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis
20. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling
21. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
22. 2,5A-dependent RNase molecules dimerize during activation by 2-5A
23. Transcriptional activation of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3
24. (2'-5')An-dependent endoribonuclease: Enzyme levels are regulated by IFNβ, IFNγ, and cell culture conditions
25. Constitutive expression of a 2', 5'-oligoadenylate synthetase cDNA results in increased antiviral activity and growth suppression
26. Activation of the IFN-inducible enzyme RNase L causes apoptosis of animal cells
27. A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system
28. 2',5'-Oligoadenylate synthetase activity in the liver and peripheral blood mononuclear cells of chronic hepatitis patients
29. Factors influencing the response to interferon therapy in chronic hepatitis C. Studies on viral genotype and induction of 2',5'oligoadenylate synthetase in the liver and peripheral blood cells
30. Downregulation of RNase L inhibitor correlates with upregulation of interferon-induced proteins (2-5A synthetase and RNase L) in patients with chronic fatigue immune dysfunction syndrome
31. RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells
32. The RNase L inhibitor (RLI) is induced by double-stranded RNA
33. RNase L inhibitor (RLI) antisense consructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells
34. Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter